Oral and cutaneous immune-related adverse events in cancer patients: Prevalence and overall survival.
Osias Vieira De Oliveira FilhoIvana Lameiras GibbonsYuri de Lima MedeirosThiago Bueno de OliveiraNathaniel Simon TreisterFábio de Abreu AlvesPublished in: Oral diseases (2024)
Cutaneous effects affected more than half of the patients, while oral effects and xerostomia were found in around 11% and 9% of patients, respectively. Concurrent chemotherapy and PD-1 + CTLA-4 were more associated with oral and cutaneous irAEs, respectively. Patients who developed such irAEs had better overall survival.